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INTRODUCTION
Right lower quadrant pain is the most common condition
necessitating surgical admission to a paediatric hospital
(Hayes, 2004; Türkyilmaz et al., 2006). The vast majority
of cases in children are due to either acute appendicitis
(AA) or acute mesenteric lymphadenitis (AML) (Khanna et
al., 1983; Macari et al., 2002; Mandell et al., 2009; Yoon et
al., 2002; Hayes, 2004). The incidence of AA is 25 cases
per 10 000 paediatric patients per year between the ages of
10 and 17 years in the United States (Yoon et al., 2002;
Saliakellis et al., 2013; Wray et al., 2013). The discharge
diagnosis was primary AML in 7–20% of paediatric pa-
tients with a clinical suspicion of AA (Macari et al., 2002;
Sicorska-Wiúneiewska et al., 2006). The treatment tactics in
these pathologies differ to a great degree. In the case of
AML, treatment is more conservative and does not require
hospitalisation (Khanna et al., 1983; Macari et al., 2002;
Hayes, 2004; Toorenvliet et al., 2011) while in the case of
AA immediate hospitalisation is mandatory and with per-
haps further surgery (Wray et al., 2013). Missing the
diagnosis of AA in the emergency department may increase
the probability of perforation of the appendix as well as the
rate of other complications (Yoon et al., 2002; Chang et al.,
2010; Saliakellis et al., 2013; Wray et al., 2013). The rate of
perforated appendicitis has been reported as high as
10–20% in children 10–17 years of age (Wray et al., 2013).
AA and AML in children remain the difficult differential di-
agnosis for physicians. One of the most significant factors
affecting the diagnostic difficulties of these diseases in Lat-
via is the lack of equipment and specialists in radiological
methods in emergency units to make the accurate diagnosis
of AA and AML. Therefore, we need widely available and
practicable laboratory tests to support diagnoses.
The diagnostic value of some inflammatory variables de-
pends on the etiology and pathogenesis of AA and AML
(Khanna et al., 1983; Yoon et al., 2002; Türkyilmaz et al.,
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The aim of this study was to investigate the role of serum cytokines in the diagnosis of acute ap-
pendicitis (AA) and acute mesenteric lymphadenitis (AML). Data were collected prospectively on
7 to 18 year old children (October 2010 – October 2013): 31 patients with AA, 26 patients with
AML, and 17 patients with elective non-inflammatory surgical disease were selected as controls.
Serum levels of IL-10, IL-12(p70), IL-1, IL-4, IL-6, IL-8, IL-17, MCP-1, EGF, TNF- were mea-
sured. Patients with AA had significantly increased serum levels of IL-6(1) (z = -3.72; p = 0.0002)
and IL-10(1) (z = -2.81; p = 0.005) compared to AML before any treatment. The consecutive mea-
surements of MCP-1 in serum demonstrated a significant difference within 72 hours in the AA
group (Wilks’ Lambda test 0.80; F(2;29) = 3.5; p = 0.04) and also in the AML group (Wilks’
Lambda test 0.70; F(2;24) = 5.0; p = 0.01). The increased values of IL-6 and IL-10 were the most
reliable cytokines one hour before surgical intervention for patients with AA. MCP-1 values
changed significantly within 72 hours after patient hospitalisation but did not differ between the
groups, and could not be a helpful serum biomarker in distinguishing patients with AA and AML.
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2006). Appendicitis arises from an initial luminal obstruc-
tion of the appendix (Hayes, 2004; Tsuji et al., 1990;
Lamps et al., 2008). This results in local edema secondary
to impaired blood and lymphatic flow. Soon the bacterial
barrier function of the appendix epithelium fails and bacte-
rial invasion into the submucosal layers occurs (Lamps et
al., 2008). The presence of bacteria in these areas results in
the activation of immune defence and local infiltration by T
cells, monocytes, and natural killer cells. Locally, inter-
leukins and chemokines are released to recruit these cells
(Hessle et al., 1999; Yoon et al., 2002; Dala et al., 2005;
Manuzak et al., 2012; Arlt et al., 2013; Saliakellis et al.,
2013). Cytokines, composed of polypeptides and glyco-
proteins, are biological active substances with molecular
weight of 8 to 30 kDa, which participate in cellular immu-
nity in response to specific inflammatory process in the
body (Dala et al., 2005). We hypothesise that the serum
cytokine response of a patient with AA is different from
that of a patient with AML. The aim of this study was to in-
vestigate the role of serum cytokines (interleukin-10
(IL-10), interleukin-12(p70) (IL-12(p70)), interleukin-1
beta (IL-1), interleukin-4 (IL-4), interleukin-6 (IL-6),
interleukin-8 (IL-8), interleukin-17 (IL-17), monocyte
chemoattractant protein-1 (MCP-1), epithelial growth factor
(EGF), tumour necrosis factor- (TNF-)) as indicators in
the early diagnosis of AA and AML in children aged be-
tween 7 and 18 years.
MATERIALS AND METHODS
Subjects and study design. This study was approved by
the local Ethics Review Board of the Children’s University
Hospital, Rîga, Latvia (No. 40003457128). All of the pa-
tients and parents gave their informed consent to participate
in the study. The prospective case-control study was con-
ducted at the Department of Paediatric Surgery, Children’s
University Hospital, Rîga, Latvia, on 74 patients aged be-
tween 7 and 18 years from October 2010 to October 2013,
who were admitted for surgical evaluation and treatment
with suspicion of AA.
The studied patients had to meet the following inclusion cri-
teria: children aged between 7 and 18 years hospitalised in
the Children’s University Hospital of Latvia, able to obtain
parental or legal guardian written informed consents as reg-
ulated by local laws and regulations, evidence of AA in the
abdominal ultrasonography (appendix more than 6 mm di-
ameter and is not compressible) or evidence of AML in the
abdominal ultrasonography (three and more enlarged
mesenteric lymph nodes, short axis 10 mm and more), and
at least one of clinical symptom (abdominal pain, nausea,
rebound tenderness, fever 37.3 °C, white blood cell
(WBC) count >10 x 103/µL). If the patient was female of
child- bearing potential she had have a negative pregnancy
test. Exclusion criteria were diabetes, septic shock, severe
acute renal and liver impairment and chronic hepatic im-
pairment, known immunosuppression, clinical manifesta-
tion of intestinal malabsorption, chronic inflammatory
bowel diseases, infections originating from the female geni-
tal tract, perforation of the upper gastrointestinal tract, pres-
ence of liver and spleen abscess, all pancreatic processes,
gastrostomy, an indwelling peritoneal catheter, operated ab-
dominal trauma in past, systemic antibacterial treatment
within the previous seven days, and non-steroidal inflam-
matory drug and hormonal treatment within 30 days. To
minimise selection bias, all patients meeting the inclusion
criteria were evaluated by one of five consultant surgeons to
establish eligibility and perform study enrolment.
The patients were divided into three groups according to
their outcomes and inclusion and exclusion criteria. The
first study group consisted of 31 patients who were taken to
the operating theatre for appendectomy and AA confirmed
by intraoperative findings and pathological examination of
the excised appendix (AA group). All these subjects under-
went conventional open appendectomy with right lower
quadrant incision by the consultant surgeon. A pathologist
blinded to other clinical data confirmed the diagnosis of
AA. Cultures of the peritoneal fluid during appendectomy
were obtained only for patients with evidence of gross per-
foration of appendix. Peritoneal culture specimens were
tested at the local microbiology laboratory. The second
study group consisted of 26 patients with AML confirmed
by ultrasound examination and who did not undergo surgi-
cal intervention (AML group). Abdominal ultrasonography
was performed by a certified radiologist to avoid operator-
dependent differences. All patients were examined using an
ATL HDI 5000 ultrasound system (Philips Medical Sys-
tems, Bothell, Washington, United States).
The control group consisted of 17 healthy children admitted
for elective non-inflammatory surgical disease (C group).
They were selected to determine reference values of serum
cytokines EGF, IL-10, IL-12(p70), IL-1, IL-4, IL-6, IL-8,
IL-17, MCP-1, TNF-, for comparison with values of se-
rum cytokines of the AA and AML groups. All characteris-
tics of patients and the pre- and postoperative course were
recorded prospectively using standardised assessment sheets
filled out by one of the authors.
Cytokine measurements. Blood samples for the determina-
tion of cytokines were taken from patients with AA and pa-
tients with elective non-inflammatory surgical disease three
times: one hour before surgical intervention (before the on-
set of incision), and 24 and 72 hours after the surgical treat-
ment. For patients with AML, blood samples also were col-
lected three times: at hospital admission (before any
treatment was given), and 24 and 72 hours after patient hos-
pitalisation. The peripheral venous blood samples were col-
lected from an antecubital vein drawn with a sterile syringe,
transferred to a centrifuge tube. The samples were allowed
to clot for 20 to 30 min at room temperature. Serum was
separated by centrifugation at 4 oC for 20 min at 1600×g.
All specimens were immediately aliquoted, frozen and
stored at –80 oC. Serum EGF, IL-10, IL-12(p70), IL-17,
IL-1, IL-4, IL-6, IL-8, MCP-1, and TNF-a levels were
evaluated using a Milliplex Map kit (Human Cytokine /
Chemokine Magnetic Bead Panel) for Luminex xMAP
Technology (Luminex 200, Luminex Corporation, Austin,
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Texas, United States). The minimum detectable level of the
assay kit was 3.2 ng/mL for all cytokines.
Statistical analysis. The data were examined for normality
of distribution by the Shapiro-Wilks test. In case of rejec-
tion of normality, a nonparametric test was used. Continu-
ous data were expressed as median with range (25th and
75th percentile). The Kruskal-Wallis test was used for three
group comparisons. The concentrations of cytokines in the
first serum assay were compared among all study groups. In
case of significance, individual differences were identified
with a Mann-Whitney U test. Each serum sample of the AA
group was compared with the corresponding sample of the
C group. Categorical variables were analysed with a chi-
square test. A probability p value of < 0.05 was considered
as statistically significant. Statistical analyses were per-
formed using SPSS Statistics for Windows version 20.0
package software (SPSS Inc., United States).
RESULTS
This report is based on 57 patients: 35 (61.4%) boys and 22
(38.4%) girls) with mean age 12.9 years (SD 3.2). Struc-
tured histopathological examination of the excised appendix
showed that ten patients had complicated (gangrenous or
perforated) AA and 21 had uncomplicated (acute or phleg-
manous) AA. Of the 31 patients with AA, ten peritoneal
cultures were obtained, of which six were positive. Escheri-
chia coli, Bacteroides, Pseudomonas, Clostridia, Entero-
cocci, Streptococcus and Staphylococcus were isolated from
the specimens (data not shown). Abdominal ultrasound was
performed for all study patients. Enlarged abdominal lymph
nodes were detected simultaneously with inflamed appendix
in three subjects with AA. Appendectomy was performed
and phlegmonous inflammation of appendix was confirmed
in all; therefore none were excluded from study. Compari-
son of demographic features of the study subjects are shown
in Table 1. The median length of symptoms before hospi-
talisation as reported by the patient was 20 hours for AA
and 42 hours for AML. A significant difference between
these groups was not found.
The C group consisted of 17 healthy children: 9 (52.9%)
boys and 8 (47.1%) girls with mean age of 13.2 years (SD
3.54). They underwent laparoscopic ovarian cystectomy,
varicocelectomy, open umbilical and inguinal hernia repair
and circumcision procedure, with mean WBC count 6.3 (1
SD) x 103/µL.
The cytokines IL-10, IL-12(p70), IL-1, IL-4, IL-6, IL-8,
IL-17, MCP-1, EGF, and TNF- levels obtained consecu-
tively at the different time points in the AA and AML
groups are presented together with the reference values of
the control group in Table 2 and 3.
Consecutive measurements of IL-6 and MCP-1 in serum in
the AA group demonstrated a significant difference between
values one hour before the surgical intervention and 72
hours after the operation (Wilks’ Lambda test 0.80;
T a b l e 1










(AA group) (AML group)
(n = 31) (n = 26)
Age, mean (SD), (years) 13.4( ± 2.5) 11.0 ( ± 2.4) NS
Gender, male 18 (58.1%) 17 (65.4%) NS
Nausea 21 (67.7%) 8 (30.8%) 0.01
Vomiting 16 (51.6%) 4 (15.4%) 0.01
Temperature  37.3°C 22 (71.0%) 15 (57.7%) NS
Rebound tenderness 31 (100.0%) 25 (96.2%) NS
WBC > 10 × 103/µL 24 (77.6%) 14 (53.8%) NS
CRP > 5 mg/L 23 (74.2%) 21 (80.8%) NS
ANC > 6.75 × 103/µL 11 (68.8%) 10 (66.7%) NS
Continuous data are expressed as means ± standard deviation (SD) and cat-
egorical data are expressed as percentages n (%); NS – not significant (p 
0.05 for all groups); WBC – white blood cell count; CRP – C reactive pro-
tein; ANC – absolute neutrophil count; Categorical data were compared by
Chi square test and continuous data compared by the Mann-Whitney test.
T a b l e 2
SERUM CYTOKINE CONCENTRATIONS OBTAINED PREOPERA-
TIVELY AND 24 AND 72 HOURS AFTER START OF THE OPERA-
TION IN THE AA GROUP AND THE REFRENCE VALUES OF
CYTOKINES IN THE C GROUP




























































































NS – not significant (p  0.05 for all groups); data are presented as median
and range (25th and 75th percentile); C – control group: reference values of
cytokines; AA group – patients with acute appendicitis; 1 – cytokine con-
centrations one hour before the operation; 2 – cytokine concentrations 24
hours after start of the operation; 3 – cytokine concentrations 72 hours after
start of the operation.
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F(2;29) = 3.5; p = 0.04) (Figs. 1 and 2). The serum levels of
MCP-1 differed significantly from the day of patient hospi-
talization to those at 72 hours after hospitalisation also in
the AML group (Wilks’ Lambda test 0.70; F(2;24) = 5.0;
p = 0.01) (Fig. 3).
More detailed analysis revealed that the concentrations of
IL-6, and IL-10 were significantly higher in all serum sam-
ples obtained from patients with AA than in patients in the
C group (IL-10(1): z = –2.29; p = 0.02; IL-10(2): z = –3.5;
p = 0.0004; IL-10(3): z = 3.59; p = 0.0003; (IL-6(1): z =
–2.55; p = 0.01; IL-6(2): z = –2.77; p = 0.006; IL-6(3): z =
–1.96; p = 0.05). The serum levels of IL-6 and IL-10 were
significantly higher one hour before surgical intervention in
the AA group compared to the corresponding values on the
day of patient admission to hospital in the AML group
(IL-6(1): z = –3.72; p = 0.0002; IL-10(1): z = –2.81; p =
0.005). The concentration of IL-12(p70) was significantly
higher in serum 24 hours after operation in the AA group
than in the C group (IL-12(p70)(2): z = –2.15; p = 0.031).
Further analysis demonstrated that 24 and 72 hours after op-
eration the concentrations of IL-1, IL-4, TNF- and EGF
were significantly different between the AA group and the
C group. The concentrations of IL-8 and MCP-1 at different
Fig. 1. Serum concentrations of IL-6 at different time points in the group of
patients with AA. IL-6(1) – cytokine concentrations one hour before the
operation; IL-6(2) – cytokine concentrations 24 hours after start of the op-
eration; IL-6(3) – cytokine concentrations 72 hours after start of the opera-
tion.
Fig. 2. Serum concentrations of MCP-1 at different time points in the
group of patients with AA. MCP-1(1)– cytokine concentrations one hour
before the operation; MCP-1(2) – cytokine concentrations 24 hours after
start of the operation; MCP-1(3) – cytokine concentrations 72 hours after
start of the operation.
T a b l e 3
SERUM CYTOKINE CONCENTRATIONS OBTAINED ON THE DAY OF PATIENT ADMISSION TO HOSPITAL AND 24 AND 72 HOURS AFTER
HOSPITALIZATION IN THE AML GROUP AND THE REFRENCE VALUES OF CYTOKINES IN THE C GROUP








EGF 106.8 (46.5–152.7) 113.1 (51.8–151.7) 123.7 (75.8–204.3) NS 87.0 (38.3–133.6)
IL-10 3.2 (3.2–3.2) 3.2 (3.2–3.2) 3.2 (3.2–3.3) NS 3.2 (3.2–3.2)
IL-12(p70) 3.2 (3.2–3.2) 3.2 (3.2–3.2) 3.2 (3.2–3.2) NS 3.2 (3.2–3.5)
IL-17 3.3 (3.2–9.1) 3.3 (3.2–10.9) 3.2 (3.2–8.6) NS 5.8 (3.2–29.5)
IL-1 3.2 (3.2–3.2) 3.2 (3.2–3.2) 3.2 (3.2–3.2) NS 3.2 (3.2–8.6)
IL-4 3.2 (3.2–3.7) 3.2 (3.2–3.2) 3.2 (3.2–3.2) NS 3.2 (3.2–3.2)
IL-6 3.2 (3.2–3.2) 3.2 (3.2–3.2) 3.2 (3.2–3.2) NS 3.2 (3.2–11.7)
IL-8 10.6 (7.0–19.2) 13.4 (7.4–20.9) 11.6 (7.3–22.1) NS 18.3 (7.1–55.3)
MCP-1 333.9 (266.0–378.2) 387.3 (250.1–431.7) 405.8 (313.6–484.2) 0.01 352.9 (235.8–520.7)
TNF- 14.2(11.0–19.0) 14.2(10.9–19.5) 16.4(11.5–18.8) NS 12.4 (9.9–13.4)
NS – not significant (p  0.05 for all groups); data are presented as median and range (25th and 75th percentile); C – control group: reference values of
cytokines; AML group – patients with acute mesenteric lymphadenitis; 1 – cytokine concentrations on the day of patient admission to hospital; 2 – cytokine
concentrations 24 hours after the hospitalization; 3 – cytokine concentrations 72 hours after the hospitalization.
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time points in these study subgroups did not differ signifi-
cantly.
DISCUSSION
Patients with AML typically have a history of fever and ab-
dominal pain, frequently with localisation in the right lower
quadrant (Macari et al., 2002; Hayes, 2004; Sicorska-
Wiúneiewska et al., 2006; Mandell et al., 2009; Toorenvliet
et al., 2011). The clinical presentation is similar to that of
acute AA (Khanna et al., 1983; Yoon et al., 2002;
Toorenvliet et al., 2011; Saliakellis et al., 2013). Few data
are available on the incidence of this syndrome, and it may
vary with the geographic location. In one series of hospita-
lised patients, 50 of 651 (7.7%) admitted with a diagnosis of
AA had a discharge diagnosis of AML (Mandell et al.,
2009).
In most cases, gut bacteria have a possible role in causing
common clinical symptoms of both mentioned diseases.
Bacteriologic studies of nonspecific AA using microbio-
logic culture techniques have revealed a wide variety of an-
aerobic and aerobic bacteria that are present in these dis-
eases (Lamps, 2008; 2010; Arlt et al., 2013; ). Nonspecific
AML organisms isolated in culture include Escherichia
coli, Bacteroides, Clostridia species, Enterococci, beta-
hemolytic Streptococcus, Staphylococcus aureus and
Yersinia (Khanna et al., 1983). These microbes were also
observed in the present study, and Pseudomonas was iso-
lated from some specimens of patients with AA. The char-
acter of bacteria is a major factor in determining their arrest
in lymph nodes (Khanna et al., 1983; Mandell et al., 2009).
Therefore, it is possible that different cytokines can appear
in blood at the early stages of AML. It was observed (Li et
al., 2010) that Staphylococcus aureus infection was reduced
by local MCP-1 therapy aimed at monocyte and macro-
phage recruitment in the first 48 hours at the site of infec-
tion. According to our study, MCP-1 levels in serum also
significantly increased at 42 hours from start of symptoms
to 72 hours after patient hospitalisation with AML.
Previously, studies examining the immunologic response to
enteric bacteria within the intestinal lumen have shown spe-
cific cytokine production by certain bacteria, which might
aid diagnosis of AA (Arlt et al., 2013). Two important
immunoregulatory cytokines produced by cells of the innate
defense system in response to bacteria are IL-12(p70) and
IL-10. IL-12(p70) stimulates interferon-gamma (IFN-) pro-
duction from T cells and natural killer (NK) cells and in-
creases their cytotoxicity (Hessle et al., 1999). IL-10 was
identified as a cytokine synthesis response inhibitory factor
that is secreted as a part of Th2 response and that inhibits
interleukin-2 and IFN- production by Th1 cells (Shaheen et
al., 2009). In the present study these same pro-inflammatory
and anti-inflammatory cytokines were observed and their
levels significantly differed at different time points of AA.
The concentration of IL-12(p70) was significantly higher in
serum 24 hours after the operation in the AA group,
comparted to that healthy subjects. However, the IL-10
level was significantly higher in serum obtained 22 hours
after the patient felt ill in the AA group, compared to the
that in the C group. Previously it was observed that IL-6
and IL-10 had high concentration in the serum of patients
with uncomplicated AA, while the proinflammatory
cytokines (IL-1, IL-12(p70), TNF-) had low concentra-
tion in these patient (Rivera-Chavez et al., 2003). Cytokine
profiles in whole peripheral blood mononuclear cells was
found to differ depending on the stimulating bacterial spe-
cies: Bacteroides fragilis induced significantly more pro-
duction of IL-12(p70) and interleukin-23 than Escherichia
coli and Enterococcus, although Escherichia coli and
Enterococcus induced levels of IL-10 that were signifi-
cantly higher than the level induced by Bacteroides fragile
(Manuzak et al., 2012). These findings indicate that IL-10
and IL-12(p70) might be important diagnostic serum mark-
ers for AA arising due to commensal enteric bacteria. We
emphasize that we only found significant increased secre-
tion of IL-10 and IL-6 one hour before the surgical inter-
vention in the cases of AA, while the corresponding values
were observed on the day of AML patient admission to hos-
pital. It is possible that AA and AML might be due to en-
teric bacteria. Consequently, enlarged abdominal lymph
nodes can appear simultaneously with the inflamed appen-
dix as a result of more severe local inflammation in appen-
dix and bacterial translocation (Österberg et al., 2004). In
our study, enlarged abdominal lymph nodes were detected
simultaneously with the inflamed appendix in three patients
with AA. In an experimental study with mice where release
of cytokines was stimulated by an innate immune regulatory
factor, IL-10 began to appear after three hours, peaked at
eight hours and returned to baseline by 36 hours, indicating
that high concentrations in blood are achieved rapidly after
the onset of bacterial invasion (Parker et al., 2011). In-
creased levels of IL-10 and infiltration of polymorpho-
nuclear leukocyte and plasma cell isotypes in the lamina
propria of the appendix at 30 minutes were observed fol-
Fig. 3. Serum concentrations of MCP-1 at different time points in the
group of patients with AML. MCP-1(1) – cytokine concentrations on the
day of patient admission to hospital; MCP-1(2) – cytokine concentrations
24 hours after the hospitalization; MCP-1(3) – cytokine concentrations 72
hours after the hospitalization.
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lowing experimental obstruction of the appendix lumen in
24 New Zealand-bred white rabbits (Tsuji et al., 1990).
Similarly, in our study the highest concentration of IL-10
occurred 22 h after AA patients felt ill.
IL-6 has a broad range of activity on multiple cells types
and it induces a broad array of responses (Shaheen et al.,
2009). One of these is acute phase response followed by
bacterial endotoxemia (Brãnescu et al., 2013; Saliakellis et
al., 2013). Brãnescu et al. (2013) found preoperatively that
IL-6 in serum exceeded a maximum value of 9.7 pg/mL in
93.7% of studied subjects with phlegmanous inflammation
of appendix. This is consistent with our finding that preop-
eratively concentration of IL-6 was significantly higher (8.0
pg/mL) in patients with AA, compared to its concentration
(3.2 pg/mL) on the day of AML patient admission to hospi-
tal. This can be explained also by the fact that there were
more cases of uncomplicated AA in our study than compli-
cated AA. Previous study (Gûrleik et al., 2002) showed that
measurement of IL-6 concentration did not benefit in in-
creasing the accuracy of diagnosis of AA, as the false posi-
tive rate of the test was 54% in normal appendectomy cases,
and the false negative rate was 19% in patients with
non-perforated AA. We observed a significant difference
between the levels of IL-6 cytokine at one hour before sur-
gical intervention to 72 hours after the operation in the
cases of AA. Sakamoto et al. (2003) found that serum IL-6
levels reached a maximum within the first postoperative day
and decreased thereafter, which was explained by surgical
trauma whereby IL-6 was produced in the operative field
and entered the peripheral blood stream to induce elevation
of serum IL-6. Examination of serum inflammatory markers
in AA and AML cases might be helpful in differentiating
the stage of inflammation, as most patients are healthy be-
fore developing AA and AML and since the length of
symptoms before hospitalisation is typically less than 48
hours (Rivera-Chavez et al., 2003).
A limitation of this study was the small number of patients.
One of the reasons for this was due to the exclusion criteria
of use of non-steroidal inflammatory and antibacterial treat-
ment before the patient has admitted to hospital with AA
and AML. The most significant factors affecting the diag-
nostic difficulties of both these diseases in Latvia is the lack
of equipment and specialists in radiological methods in
emergency units to make the accurate diagnose of AA and
AML. Therefore, we need widely available and practicable
laboratory tests to support diagnoses that would result from
future research. In future, the study population should be in-
creased and the additional analysis of clinical parameters is
needed.
The increased cytokines serum concentrations of IL-6 and
IL-10 were the most reliable indicators one hour before the
surgical intervention (the median length of symptoms was
22 h) for patients with AA. MCP-1 values significantly dif-
fered 72 h after patient hospitalization compared to values
at other time points, but did not differ between the AA and
AML groups. Therefore, MCP-1 is not a useful serum bio-
marker in distinguishing patients with AA and AML.
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ATÐÍIRÎGA CITOKÎNU GRUPAS SERUMA IEKAISUMA MEDIATORU IZPAUSME AKÛTA APENDICÎTA UN AKÛTA
MEZENTERIÂLA LIMFADENÎTA GADÎJUMÂ BÇRNIEM
Citokînu grupas seruma iekaisuma mediatoru nozîme atkarîga no akûta apendicîta (AA) un akûta mezenteriâla limfadenîta (AML)
etioloìijas un patoìençzes. Pçtîjuma mçríis bija atklât daþâdu seruma citokînu nozîmi AA un AML diagnostikâ bçrniem. Pçtîjumâ tika
iekïauti 74 pacienti (7–18 gadi), kuri ârstçti VSIA Bçrnu klîniskajâ universitâtes slimnîcâ (BKUS), bçrnu íirurìijas nodaïâ (2010–2013).
Atbilstoði pçtîjuma mçríim bçrni tika sadalîti divâs grupâs: 31 pacienti AA grupâ un 26 pacienti AML grupâ. Pçtîjuma kontroles grupâ tika
iekïauti 17 pacienti ar plânveidâ operçtâm íirurìiskâm saslimðanâm bez iekaisuma klâtbûtnes organismâ, kuri arî stacionçti VSIA BKUS
pçtîjuma veikðanas laika posmâ. Kontroles grupa tika izveidota ar mçríi noteikt citokînu referentâs vçrtîbas un tâs salîdzinât ar AA un AML
pacientu rezultâtiem. Visâs grupâs tika paòemti asins paraugi un noteikti ðâdi seruma citokîni: EGF, IL-10, IL-12(p70), IL-1, IL-4, IL-6,
IL-8, MCP-1, TNF-. Kontroles grupai un pacientiem ar AA venozie asins paraugi tika ievâkti stundu pirms operâcijas, 24 un 72 stundas
pçc operâcijas, bet AML gadîjumâ: stacionçðanas brîdî, 24 un 72 stundas pçc iestâðanâs stacionârâ. Pçtîjumâ iesaistîto pacientu ar AA un
AML vidçjais vecums 12,9 gadi (SD 3,2), no kuriem 61,4% (n = 35) bija zçni un 38,4% (n = 22) meitenes. Vidçjais vecums AA pacientu
grupâ 13,4 gadi (SD 2,5) un AML pacientiem 11,0 gadi (SD 2,4). IL-6 un MCP-1 gadîjumâ tika novçrota statistiski ticama atðíirîba
citokînu koncentrâcijai serumâ laika dinamikâ AA pacientiem (no stundu pirms operâcijas lîdz 72 stundâm pçc íirurìiskas iejaukðanâs):
Wilks’ Lambda tests 0,80; F(2;29) = 3,5; p = 0,04. AML pacientiem MCP-1 citokîna koncentrâcijai plazmâ tika novçrota statistiski ticama
atðíirîba laika dinamikâ (stacionçðanas brîdî lîdz 72 stundâm pçc stacionçðanas): Wilks’ Lambda tests 0,70; F(2;24) = 5,0; p = 0,01. IL-6 un
IL-10 koncentrâcija pirmajâ seruma paraugâ (t.i., pirms ârstçðanas uzsâkðanas) paaugstinâs pacientiem ar AA, salîdzinot ar AML
pacientiem ((IL-6(1): z = –3.72; p = 0.0002; IL-10(1): z = –2.81; p = 0.005)). Pçtîjuma rezultâtâ bûtiska IL-6 un IL-10 citokînu
koncentrâcijas paaugstinâðanâs serumâ tika novçrojama stundu pirms operâcijas, kas vidçji atbilst 20 stundu slimîbas ilgumam AA
gadîjumâ. MCP-1 gadîjumâ tika novçrota statistiski ticama atðíirîba citokînu koncentrâcijai serumâ laika dinamikâ abu pacientu grupu
iekðienç, bet ticamas atðíirîbas starp abâm ðim grupâm netika atklâtas.
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